Skip to main content
ALLIANCE PHARMA PLC logo

ALLIANCE PHARMA PLC — Investor Relations & Filings

Ticker · APH ISIN · GB0031030819 LEI · 213800RYIWZA4Q5WPZ13 IL Wholesale and retail trade
Open in API
Filings indexed 492 across all filing types
Latest filing 2015-05-27 Remuneration Information
Country GB United Kingdom
Listing IL APH

About ALLIANCE PHARMA PLC

https://www.alliancepharmaceuticals.com/

Alliance Pharma PLC is an international specialty pharmaceutical company with a primary focus on consumer healthcare. The company's business model is centered on the acquisition, licensing, and marketing of a portfolio of consumer health products and prescription medicines. It operates globally, investing in its key brands to empower consumers to improve their health and wellbeing. A core part of its strategy is the ongoing development to become a high-performing consumer healthcare company.

Recent filings

Filing Released Lang Actions
Share Options
Remuneration Information Classification · 99% confidence The document is a formal announcement disseminated via 'RNS Number' (Regulatory News Service) from the London Stock Exchange. The content explicitly details the award of 'Share Options' over ordinary shares to certain Directors, including names, positions, number of options, and exercise prices. This type of transaction report, detailing personal share dealings by company directors and executives, directly corresponds to the definition of Director's Dealing (DIRS). Although it is an RNS announcement, the specific nature of the content (insider trading/option grants) makes DIRS a more precise classification than the general RNS fallback.
2015-05-27 English
AGM Statement
Earnings Release Classification · 98% confidence The document explicitly states it is an 'AGM Statement' being delivered at the company's 'Annual General Meeting ("AGM")'. It contains a statement from the Chairman regarding trading performance, brand sales, management changes (Finance Director stepping down), and future outlook. Since it is the statement made *during* the AGM, it directly relates to the meeting proceedings and materials. This fits the definition of 'AGM Information' (Code: AGM-R) better than a general Earnings Release (ER) or Interim Report (IR), as the context is the meeting itself. Q1 2015
2015-05-27 English
Exercise of Share Options
Share Issue/Capital Change Classification · 99% confidence The document is identified by the 'RNS Number' header and explicitly states 'This information is provided by RNS The company news service from the London Stock Exchange'. The content details the exercise of employee share options and the subsequent application for admission to trading of new ordinary shares. This action directly relates to a change in the number of shares in issue, which falls under 'Share Issue/Capital Change' (SHA). However, since this is a short, immediate announcement disseminated via the RNS system, and the core action is a change in capital structure due to option exercise, SHA is the most specific fit for the corporate action described. Given the RNS context, SHA is appropriate for reporting share issuance/changes.
2015-04-15 English
Annual Report and AGM Notice
Report Publication Announcement Classification · 99% confidence The document is very short (1974 characters) and explicitly states that the '2014 Annual Report and Accounts and Notice of Annual General Meeting' are 'now available on the Company's website'. This structure—announcing the availability of other primary documents (Annual Report and AGM Notice) rather than containing the full content of those reports—fits the definition of a Report Publication Announcement (RPA). It is not the full 10-K or the AGM material itself, but the notice of their publication. The presence of an RNS Number further supports this being a regulatory announcement about published materials.
2015-04-10 English
Preliminary Results
Earnings Release Classification · 100% confidence The document is an 'Earnings Release' (ER) from Alliance Pharma PLC. It contains key financial highlights (revenue, pre-tax profit, EPS, cash flow, debt), operational highlights, and management commentary regarding the fiscal year ended 31 December 2014. It is clearly an initial announcement of financial results rather than a full Annual Report (10-K) or a transcript of a call (CT). FY 2014
2015-03-25 English
Exercise of Share Options
Share Issue/Capital Change Classification · 99% confidence The document is identified by the 'RNS Number' header and the closing statement 'This information is provided by RNS The company news service from the London Stock Exchange'. The content announces the exercise of employee share options and the subsequent application for admission to trading of 14,300 new ordinary shares. This action directly relates to changes in the company's share capital structure due to employee compensation mechanisms. While it involves shares, it is not a general share issue (SHA) or a buyback (POS), but rather a specific corporate action announcement disseminated via the Regulatory News Service (RNS). Given the nature of the announcement (insider/employee share transaction leading to new shares) and the explicit RNS tagging, the most appropriate classification is RNS, as it is a general regulatory announcement that doesn't fit the more specific categories like DIRS (which is for director's personal trades, not option exercises leading to admission) or SHA (which is broader capital change). However, since the core event is the issuance of shares following option exercise, SHA might be considered, but RNS is the mechanism used for dissemination. Given the options, RNS serves as the best fit for a standard, short regulatory news service release that isn't a full report or a specific financial event like a dividend or M&A.
2015-03-03 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.